FDA Adverse Event Malfunction Summary report: N

SUPERDIMENSION INREACH BRONCHUS SYSTEM

MDR report key: 5079148 · Received September 15, 2015

Report

Report Number
3004962788-2015-00072
Event Type
Malfunction
Date Received
September 15, 2015
Date of Event
August 17, 2015
Report Date
November 4, 2015
Manufacturer
SUPERDIMENSION INC.
Product Code
JAK
PMA / PMN Number
K092365
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). DATE OF FOLLOW-UP REPORT: 11/05/2015. A COMPONENT OF THE SUPERDIMENSION SYSTEM WAS RETURNED AND EVALUATED WHICH SHOWED THE ISSUE WAS NOT SOFTWARE RELATED. AN ON-SITE SERVICE VISIT WAS PERFORMED AND THE ISSUE COULD NOT BE NOT DUPLICATED, HOWEVER THE IPC WAS REPLACED AS A PRECAUTION. THE IPC WAS RETURNED AND EVALUATED AND THE ROOT CAUSE COULD NOT BE DETERMINED.

Additional Manufacturer Narrative · 1

(B)(4). A COMPONENT OF THE SUPERDIMENSION SYSTEM, THE WINDOWS LOGS, HAS BEEN RECEIVED AND IS UNDER EVALUATION. WHEN THE EVALUATION IS COMPLETE A FOLLOW-UP REPORT WILL BE SUBMITTED. OUT OF AN ABUNDANCE OF CAUTION, SUPERDIMENSION IS FILING THIS MDR DUE TO THE ADDITIONAL RISK ASSOCIATED WITH MULTIPLE EXPOSURES TO GENERAL ANESTHESIA. THERE WERE NO ANOMALIES IDENTIFIED DURING THE INTERNAL REVIEW OF THE DHR OF THE SYSTEM CONSOLE. IF ADDITIONAL INFORMATION IS RECEIVED A FOLLOW-UP REPORT WILL BE SUBMITTED.

Description of Event or Problem · 1

SITE REPORTED THE SUPERDIMENSION ILOGIC SYSTEM TURNED OFF DURING THE PROCEDURE AND THE PHYSICIAN CANCELED THE SUPERDIMENSION PORTION OF THE CASE. THE PATIENT WAS UNDER GENERAL ANESTHESIA. THERE WAS NO REPORT OF PATIENT INJURY, DEATH OR OTHER SERIOUS ADVERSE EVENT. IF ADDITIONAL INFORMATION PERTINENT TO THE INCIDENT IS OBTAINED A FOLLOW-UP REPORT WILL BE SUBMITTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
607951 SUPERDIMENSION INREACH BRONCHUS SYSTEM ELECTROMAGNETIC NAVIGATION BRONCHOSCOPY JAK SUPERDIMENSION INC. AAS00161-20

Patients

Seq Age Sex Outcome Treatment
1